학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 39건 | 목록
1~20
Academic Journal
Lim, Andrew; Grigoriadis, George; Walker, Trish; Nicol, Andrew; LeBlanc, Richard; Reece, Donna; Elemary, Mohamed; Boudreault Pedneault, Jean Samuel; Karlin, Lionel; Facon, Thierry; Attal, Michel; Weisel, Katja; Engelhardt, Monika; Mackensen, Andreas; Quinn, John; Avivi, Irit; Cohen, Amos; Magen-Nativ, Hila; Benyamini, Noam; Cavo, Michele; Larocca, Alessandra; Takezako, Naoki; Suzuki, Kenshi; Kosugi, Hiroshi; Matsumoto, Morio; Iida, Shinsuke; Ishikawa, Takayuki; Kondo, Yukio; Sunami, Kazutaka; Ando, Kiyoshi; Teshima, Takanori; Chou, Takaaki; Iwasaki, Hiromi; Miki, Hirokazu; Matsumura, Itaru; Onishi, Yasushi; Izutsu, Koji; Kizaki, Masahiro; George, Anupkumar; Blacklock, Hillary; Simpson, David; Schjesvold, Fredrik; Waage, Anders; Samoilova, Olga; Nikitin, Evgeniy; Chagorova, Tatiana; McDonald, Andrew; Patel, Moosa; Oriol Rocafiguera, Albert; San Miguel Izquierdo, Jesus; Mateos, Maria; Streetly, Matthew; Forsyth, Peter; Jackson, Graham; Jenkins, Stephen; Rifkin, Robert; Yimer, Habte; McCroskey, Robert; Martincic, Danko; Tarantolo, Stefano; Larson, Sarah; Faroun, Yacoub; Vaughn, Jennifer; Baz, Rachid; Saylors, Gene; Neppalli, Amarendra; Raptis, Anastasios; Fung, Henry; Janosky, Maxwell; Stevens, Don; Coleman, Morton; Costa, Dennis; Cross, Scott; Fanning, Suzanne; Berges, Daniel Farray; Harris, Thomas; Zackon, Ira; Atanackovic, Djordje; Lee, Kelvin; Oliff, Ira; Lee, Wes; Bensinger, William; Lutzky, Jose; Baron, Ari; Hayek, Fadi; Kirschner, Eli; Bharany, Neeraj; Overton, Lindsay; Mannem, Siva; Harroff, Allyson; Jain, Sharad; Roque, Tammy; McIntyre, Kristi; Yasencha, Christopher K; Houck, William; Usmani, Saad Zafar ; Oriol, Albert ; Rifkin, Robert M ; Yimer, Habte Aragaw ; McCroskey, Robert Donald ; Lim, Andrew Boon Ming ; Jagannath, Sundar ; Lonial, Sagar ; Ghori, Razi Uddin ; Farooqui, Mohammed Z H ; Marinello, Patricia ; San-Miguel, Jesus
In The Lancet Haematology September 2019 6(9):e448-e458
Academic Journal
Farooqui, Mohammed Z H ; Valdez, Janet ; Martyr, Sabrina ; Aue, Georg ; Saba, Nakhle ; Niemann, Carsten U ; Herman, Sarah E M ; Tian, Xin ; Marti, Gerald ; Soto, Susan ; Hughes, Thomas E ; Jones, Jade ; Lipsky, Andrew ; Pittaluga, Stefania ; Stetler-Stevenson, Maryalice ; Yuan, Constance ; Lee, Yuh Shan ; Pedersen, Lone B ; Geisler, Christian H ; Calvo, Katherine R ; Arthur, Diane C ; Maric, Irina ; Childs, Richard ; Young, Neal S ; Wiestner, Adrian
In Lancet Oncology February 2015 16(2):169-176
Academic Journal
Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; De Nigris E; Outcomes Research, MSD (UK) Limited, London, UK.; Leng S; Merck & Co., Inc., Rahway, NJ, USA.; Farooqui MZH; Merck & Co., Inc., Rahway, NJ, USA.; Yapici HO; Boston Strategic Partners, Inc., Boston, MA, USA.; Weimer I; Boston Strategic Partners, Inc., Boston, MA, USA.; Jiao W; Boston Strategic Partners, Inc., Boston, MA, USA.; Hyatt H; Boston Strategic Partners, Inc., Boston, MA, USA.; Zhang X; Boston Strategic Partners, Inc., Boston, MA, USA.; Lodaya K; Boston Strategic Partners, Inc., Boston, MA, USA.; Obeng-Kusi M; Merck & Co., Inc., Rahway, NJ, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Academic Journal
Itsara A; Amgen Inc., Huntsville, Alabama, United States.; Rogness VM; NIH, NHLBI, United States.; Samples L; NIH, NHLBI, Bethesda, Maryland, United States.; Yuan CM; NCI/NIH, Bethesda, Maryland, United States.; Wang HW; National Institutes of Health, Bethesda, Maryland, United States.; Ahn IE; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Farooqui MZH; NIH, Bethesda, Maryland, United States.; Tian X; National Heart, Lung and Blood Institute, Bethesda, Maryland, United States.; Sun C; National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States.; Tomasulo E; University of Pennsylvania, United States.; Soto S; Laboratory of Lymphoid Malignancies, Hematology Branch, NHLBI, NIH, Bethesda, Maryland, United States.; Superata J; National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States.; Bezkorovaynaya L; NIH, NHLBI, Bethesda, Maryland, United States.; Hughes TE; National Institutes of Health, Bethesda, Maryland, United States.; Nierman PK; National Institutes of Health, Bethesda, Maryland, United States.; Wiestner A; NIH, NHLBI, Bethesda, Maryland, United States.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Obeng-Kusi M; Merck & Co., Inc., Rahway, New Jersey, USA.; De Nigris E; MSD (UK) Limited, London, UK.; Leng S; Merck & Co., Inc., Rahway, New Jersey, USA.; Farooqui MZH; Merck & Co., Inc., Rahway, New Jersey, USA.; Yapici HO; Boston Strategic Partners, Inc., Boston, Massachusetts, USA.; Weimer I; Boston Strategic Partners, Inc., Boston, Massachusetts, USA.; Jiao W; Boston Strategic Partners, Inc., Boston, Massachusetts, USA.; Hyatt HW; Boston Strategic Partners, Inc., Boston, Massachusetts, USA.; Zhang X; Boston Strategic Partners, Inc., Boston, Massachusetts, USA.; Lodaya K; Boston Strategic Partners, Inc., Boston, Massachusetts, USA.; Dingli D; Mayo Clinic, Rochester, Minnesota, USA.
Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
Academic Journal
Lin KH; Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, Massachusetts, USA, dana-farber.org.; Huynh L; Analysis Group, Inc., Boston, Massachusetts, USA.; Yang X; Merck & Co., Inc., Rahway, New Jersey, USA.; Zanardo E; Analysis Group, Inc., Boston, Massachusetts, USA.; Liborski D; Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, Massachusetts, USA, dana-farber.org.; McDonough MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, Massachusetts, USA, dana-farber.org.; Farooqui MZH; Merck & Co., Inc., Rahway, New Jersey, USA.; De Nigris E; MSD (UK) Limited, London, UK.; Gandra SR; Merck & Co., Inc., Rahway, New Jersey, USA.; Duh MS; Analysis Group, Inc., Boston, Massachusetts, USA.; Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, Massachusetts, USA, dana-farber.org.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, Massachusetts, USA, dana-farber.org.
Publisher: Wiley Country of Publication: United States NLM ID: 101504271 Publication Model: eCollection Cited Medium: Print ISSN: 1687-9104 (Print) Linking ISSN: 16879104 NLM ISO Abbreviation: Adv Hematol Subsets: PubMed not MEDLINE
Academic Journal
Huntington SF; Yale School of Medicine, New Haven, CT, USA.; Cheng WY; Analysis Group, Inc, Boston, MA, USA.; Sarpong EM; Merck & Co., Inc, Rahway, NJ, USA.; Leng S; Merck & Co., Inc, Rahway, NJ, USA.; Farooqui MZH; Merck & Co., Inc, Rahway, NJ, USA.; Agu US; University of Arizona, Tucson, AZ, USA.; Catillon M; Analysis Group, Inc, Boston, MA, USA.; Lejeune D; Groupe d'analyse, Ltée, Montréal, QC, Canada.; Downes N; Analysis Group, Inc, Boston, MA, USA.; Matay L; Analysis Group, Inc, Boston, MA, USA.; Duh MS; Analysis Group, Inc, Boston, MA, USA.; De Nigris E; MSD (UK) Limited, London, UK.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Baskar S; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Peng H; Department of Immunology and Microbiology, The Herbert Wertheim University of Florida Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL.; Gaglione EM; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA.; Carstens EJ; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Lindorfer MA; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA.; Ahn IE; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Herman SEM; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Skarzynski M; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Chang J; Department of Immunology and Microbiology, The Herbert Wertheim University of Florida Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL.; Keyvanfar K; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Butera V; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Blackburn A; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Vire B; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Maric I; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.; Stetler-Stevenson M; Flow Cytometry Unit, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Yuan CM; Flow Cytometry Unit, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Eckhaus MA; Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, MD.; Soto S; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Farooqui MZH; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Taylor RP; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA.; Rader C; Department of Immunology and Microbiology, The Herbert Wertheim University of Florida Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL.; Wiestner A; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
André, Thierry; Shiu, Kai-Keen; Kim, Tae Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis; Smith, Denis; Garcia-Carbonero, Rocio; Benavides, Manuel; Gibbs, Peter; de la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Bendell, Johanna; Le, Dung T; Yoshino, Takayuki; Van Cutsem, Eric; Yang, Ping; Farooqui, Mohammed Z H; Marinello, Patricia; Diaz, Luis A; KEYNOTE-177 Investigators; Van den Eynde, Marc
The New England journal of medicine, Vol. 383, no.23, p. 2207-2218 (2020)
André, T, Shiu, K-K, Kim, T W, Jensen, B V, Jensen, L H, Punt, C, Smith, D, Garcia-Carbonero, R, Benavides, M, Gibbs, P, de la Fouchardiere, C, Rivera, F, Elez, E, Bendell, J, Le, D T, Yoshino, T, Van Cutsem, E, Yang, P, Farooqui, M Z H, Marinello, P, Diaz, L A & KEYNOTE-177 Investigators 2020, ' Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer ', The New England Journal of Medicine, vol. 383, no. 23, pp. 2207-2218 . https://doi.org/10.1056/NEJMoa2017699
André, T, Shiu, K-K, Kim, T W, Jensen, B V, Jensen, L H, Punt, C, Smith, D, Garcia-Carbonero, R, Benavides, M, Gibbs, P, de la Fouchardiere, C, Rivera, F, Elez, E, Bendell, J, Le, D T, Yoshino, T, Van Cutsem, E, Yang, P, Farooqui, M Z H, Marinello, P, Diaz, L A & KEYNOTE-177 Investigators 2020, ' Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer ', The New England Journal of Medicine, vol. 383, no. 23, pp. 2207-2218 . https://doi.org/10.1056/NEJMoa2017699
Academic Journal
Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ambrose J; Cancer Outcomes Research and Evaluation, COTA, Inc, New York, NY.; de Nigris E; Outcomes Research, MSD (UK) Limited, London, UK.; Prescott J; Epidemiology, Merck & Co, Inc, Rahway, NJ.; Leng S; Clinical Development, Merck & Co, Inc, Rahway, NJ.; Farooqui MZH; Clinical Development, Merck & Co, Inc, Rahway, NJ.; Gandra SR; Outcomes Research, Merck & Co, Inc, Rahway, NJ.; Zettler CM; Cancer Outcomes Research and Evaluation, COTA, Inc, New York, NY.; Fernandes LL; Cancer Outcomes Research and Evaluation, COTA, Inc, New York, NY.; Wang CK; Cancer Outcomes Research and Evaluation, COTA, Inc, New York, NY.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center and Hematology & Medical Oncology Division at University of Washington, Seattle, WA.
Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE
Academic Journal
Ahn, Inhye E; Farooqui, Mohammed Z H; Tian, Xin; Valdez, Janet; Sun, Clare; Soto, Susan; Lotter, Jennifer; Housel, Stephanie; Stetler-Stevenson, Maryalice; Yuan, Constance M; Maric, Irina; Calvo, Katherine R; Nierman, Pia; Hughes, Thomas E; Saba, Nakhle S; Marti, Gerald E; Pittaluga, Stefania; Herman, Sarah E M; Niemann, Carsten U; Pedersen, Lone B; Geisler, Christian H; Childs, Richard; Aue, Georg; Wiestner, Adrian
Blood. 131:2357-2366
Academic Journal
Woyach JA; Ohio State University, Columbus, Ohio.; Stephens DM; Huntsman Cancer Institute, Salt Lake City, Utah.; Flinn IW; Sarah Cannon Research Institute, Nashville, Tennessee.; Bhat SA; Ohio State University, Columbus, Ohio.; Savage RE; ArQule, Inc., Burlington, MA.; Chai F; ArQule, Inc., Burlington, MA.; Eathiraj S; ArQule, Inc., Burlington, MA.; Reiff SD; Ohio State University, Columbus, Ohio.; Muhowski EM; Ohio State University, Columbus, Ohio.; Granlund L; ArQule, Inc., Burlington, MA.; Szuszkiewicz L; Ohio State University, Columbus, Ohio.; Wang W; Veristat, LLC, Southborough, Massachusetts.; Schwartz B; ArQule, Inc., Burlington, MA.; Ghori R; Merck & Co., Inc., Rahway, New Jersey.; Farooqui MZH; Merck & Co., Inc., Rahway, New Jersey.; Byrd JC; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Conference
Yoshino, T.; Kim, T. W.; Yong, W. P.; Shiu, Kai-Keen; Jensen, Benny Vittrup; Jensen, Lars Henrik; Smith, D; Garcia-Carbonero, Rocio; Alcaide-Garcia, J.; Gibbs, P.; de la Fouchardiere, Christelle; Rivera, F.; Elez, Elena; Bendell, Johanna; Le, Dung T; Yang, P.; Farooqui, Mohammed Z H; Marinello, Patricia; Diaz, Luis A.; André, Thierry
Yoshino, T, Kim, T W, Yong, W P, Shiu, K-K, Jensen, B V, Jensen, L H, Smith, D, Garcia-Carbonero, R, Alcaide-Garcia, J, Gibbs, P, de la Fouchardiere, C, Rivera, F, Elez, E, Bendell, J, Le, D T, Yang, P, Farooqui, M, Marinello, P, Diaz, L A & Andre, T 2020, ' Pembrolizumab vs chemotherapy in patients with microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: Asia subgroup results of the phase III KEYNOTE-177 study ', Annals of Oncology, vol. 31, no. Suppl. 6, 112P, pp. S1284-S1285 . https://doi.org/10.1016/j.annonc.2020.10.132
Report
Mateos MV; Complejo Asistencial Universitario de Salamanca/IBSAL & Centro de Investigación del Cáncer (IBMCC-CSIC-USAL), Salamanca, Spain.; Orlowski RZ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL) & University of Cantabria, Santander, Spain.; Rodríguez-Otero P; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.; Reece D; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Moreau P; University Hospital Hotel-Dieu, Nantes, France.; Munshi N; Dana-Farber Cancer Institute, Boston, MA, USA.; Avigan DE; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Siegel DS; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA.; Ghori R; Merck & Co, Inc, Kenilworth, NJ, USA.; Farooqui MZH; Merck & Co, Inc, Kenilworth, NJ, USA.; Marinello P; Merck & Co, Inc, Kenilworth, NJ, USA.; San-Miguel J; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Academic Journal
Ribrag V; Institut Gustave Roussy, Villejuif, France.; Avigan DE; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Green DJ; University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA.; Wise-Draper T; University of Cincinnati Cancer Institute, Cincinnati, OH.; Posada JG; Central Texas Veterans Affairs Health Care System, Temple, TX.; Vij R; Center for Advanced Medicine, Washington University School of Medicine, St. Louis, MO.; Zhu Y; Merck & Co., Inc., Kenilworth, NJ.; Farooqui MZH; Merck & Co., Inc., Kenilworth, NJ.; Marinello P; Merck & Co., Inc., Kenilworth, NJ.; Siegel DS; Hackensack University Medical Center, Hackensack, NJ.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Conference
Yoshino, Takayuki; Kim, Tae Won; Yong, Wei Peng; Shiu, Kai-Keen; Jensen, Benny Vittrup; Jensen, Lars Henrik; Smith, Denis; Garcia-Carbonero, Rocio; Alcaide-Garcia, Julia; Gibbs, Peter; de la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Bendell, Johanna; Le, Dung T; Yang, Ping; Farooqui, Mohammed Z H; Marinello, Patricia; Diaz, Luis A.; André, Thierry
Yoshino, T, Kim, T W, Yong, W P, Shiu, K-K, Jensen, B V, Jensen, L H, Smith, D, Garcia-Carbonero, R, Alcaide-Garcia, J, Gibbs, P, De la Fouchardiere, C, Rivera, F, Elez, E, Bendell, J, Le, D T, Yang, P, Farooqui, M, Marinello, P, Diaz, L A & Andre, T 2021, ' Pembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177 ', Annals of Oncology, vol. 32, no. Suppl. 4, PS1-2, pp. S284 . https://doi.org/10.1016/j.annonc.2021.05.518
Conference
André, Thierry; Amonkar, M.; Norquist, J.; Shiu, Kai-Keen; Kim, T. W.; Jensen, B. V.; Jensen, Lars Henrik; Punt, Cornelis J A; Smith, D; Garcia-Carbonero, Rocio; Sevilla, I.; de la Fouchardiere, Christelle; Rivera, F.; Elez, Elena; Diaz, Luis A.; Yoshino, T.; Van Cutsem, E; Yang, P.; Farooqui, Mohammed Z H; Le, Nhu D
Andre, T, Amonkar, M, Norquist, J, Shiu, K-K, Kim, T W, Jensen, B V, Jensen, L H, Punt, C J, Smith, D, Garcia-Carbonero, R, Sevilla, I, de la Fouchardiere, C, Rivera, F, Elez, E, Diaz, L A, Yoshino, T, Van Cutsem, E, Yang, P, Farooqui, M Z H & Le, D 2020, ' Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study ', Annals of Oncology, vol. 31, no. Suppl. 4, 396O, pp. S409 . https://doi.org/10.1016/j.annonc.2020.08.507
Academic Journal
Landau DA; New York Genome Center, New York, NY, 10013, USA.; Broad Institute, Cambridge, MA, 02142, USA.; Meyer Cancer Center & Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Sun C; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA.; Rosebrock D; Broad Institute, Cambridge, MA, 02142, USA.; Herman SEM; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA.; Fein J; New York Genome Center, New York, NY, 10013, USA.; Meyer Cancer Center & Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Sackler Medical School, Tel Aviv University, Tel Aviv, 6997801, Israel.; Sivina M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Underbayev C; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA.; Liu D; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA.; Hoellenriegel J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Ravichandran S; Advanced Biomedical Computing Center, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, MD, 21701, USA.; Farooqui MZH; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA.; Zhang W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Cibulskis C; Broad Institute, Cambridge, MA, 02142, USA.; Zviran A; New York Genome Center, New York, NY, 10013, USA.; Meyer Cancer Center & Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Neuberg DS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Livitz D; Broad Institute, Cambridge, MA, 02142, USA.; Bozic I; Department of Applied Mathematics, University of Washington, Seattle, WA, 98195, USA.; Leshchiner I; Broad Institute, Cambridge, MA, 02142, USA.; Getz G; Broad Institute, Cambridge, MA, 02142, USA.; Burger JA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Wiestner A; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA. wiestnea@nhlbi.nih.gov.; Wu CJ; Broad Institute, Cambridge, MA, 02142, USA. cwu@partners.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. cwu@partners.org.; Harvard Medical School, Boston, MA, 02215, USA. cwu@partners.org.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Bitar C; Department of Medicine, Tulane University, New Orleans, Louisiana2Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Farooqui MZ; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Valdez J; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Saba NS; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland3Section of Hematology and Medical Oncology, Department of Medicine, Tulane University, New Orleans, Louisiana.; Soto S; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Bray A; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Marti G; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Wiestner A; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Cowen EW; Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Academic Journal
Liao JJZ; Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA. Electronic address: a4statistics@gmail.com.; Farooqui MZH; Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA.; Marinello P; Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA.; Hartzel J; Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA.; Anderson K; Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA.; Ma J; Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA.; Gause CK; Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA.
Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Farooqui, Mohammed Z H
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어